Arena Pharmaceuticals Inc (NASDAQ:ARNA)
| 71.51 Delayed Data As of Mar 04 |  -1.75 / -2.39%Today’s Change | 32.95 Today|||52-Week Range 90.19 | -6.92% Year-to-Date |
Latest ARNA News | Press Releases
| Arena (ARNA) Tumbles as Mid-Stage Gastrointestinal Study Fails Mar 03 / Zacks.com - Paid Partner Content | Arena Pharmaceuticals Inc (ARNA) Q4 2020 Earnings Call Transcript Feb 24 / MotleyFool.com - Paid Partner Content |
| Arena (ARNA) Q4 Earnings Miss Estimates, Pipeline Progresses Feb 24 / Zacks.com - Paid Partner Content | Drug/Biotech Stock Q4 Earnings on Feb 23: JAZZ, ARNA & More Feb 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 73.26 |
| Today’s open | 73.13 |
| Day’s range | 70.86 - 74.56 |
| Volume | 1,079,346 |
| Average volume (3 months) | 651,617 |
| Market cap | $4.9B |
Data as of 4:00pm ET, 03/04/2021
Growth & Valuation
| Earnings growth (last year) | -192.53% |
| Earnings growth (this year) | -14.84% |
| Earnings growth (next 5 years) | -96.93% |
| Revenue growth (last year) | -99.96% |
| P/E ratio | NM |
| Price/Sales | 13,190.40 |
| Price/Book | 4.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SAGESAGE Therapeutics In... | -5.52 | -7.25% |
| HCMHutchison China Medi... | -2.15 | -7.16% |
| CCXIChemoCentryx Inc | -5.15 | -8.26% |
| CBPOChina Biologic Produ... | +0.06 | +0.05% |
Data as of 4:00pm ET, 03/04/2021
Financials
| Next reporting date | May 11, 2021 |
| EPS forecast (this quarter) | -$2.16 |
| Annual revenue (last year) | $319.0K |
| Annual profit (last year) | -$404.7M |
| Net profit margin | -126,875.86% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
